Alaunos Therapeutics, Inc. (TCRT)
1.855
+0.02
(+0.82%)
USD |
NASDAQ |
Nov 06, 09:59
Alaunos Therapeutics Price to Book Value : 7.073 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 7.016 |
| November 04, 2026 | 6.864 |
| November 03, 2026 | 7.092 |
| November 02, 2026 | 6.673 |
| October 30, 2026 | 7.435 |
| October 29, 2026 | 7.207 |
| October 28, 2026 | 8.122 |
| October 27, 2026 | 7.855 |
| October 26, 2026 | 8.122 |
| October 23, 2026 | 8.694 |
| October 22, 2026 | 11.59 |
| October 21, 2026 | 11.74 |
| October 20, 2026 | 11.32 |
| October 19, 2026 | 11.93 |
| October 16, 2026 | 10.03 |
| October 15, 2026 | 8.312 |
| October 14, 2026 | 7.893 |
| October 13, 2026 | 11.55 |
| October 12, 2026 | 4.004 |
| October 09, 2026 | 2.996 |
| October 08, 2026 | 2.978 |
| October 07, 2026 | 3.196 |
| October 06, 2026 | 2.831 |
| October 05, 2026 | 3.032 |
| October 02, 2026 | 3.127 |
| Date | Value |
|---|---|
| October 01, 2026 | 3.508 |
| September 30, 2026 | 3.384 |
| September 29, 2026 | 3.662 |
| September 28, 2026 | 3.889 |
| September 25, 2026 | 4.156 |
| September 24, 2026 | 4.309 |
| September 23, 2026 | 4.385 |
| September 22, 2026 | 4.843 |
| September 21, 2026 | 4.804 |
| September 18, 2026 | 4.576 |
| September 17, 2026 | 6.101 |
| September 16, 2026 | 4.881 |
| September 15, 2026 | 5.376 |
| September 14, 2026 | 5.681 |
| September 11, 2026 | 5.758 |
| September 10, 2026 | 5.947 |
| September 09, 2026 | 5.948 |
| September 08, 2026 | 5.986 |
| September 04, 2026 | 6.215 |
| September 03, 2026 | 6.292 |
| September 02, 2026 | 6.368 |
| September 01, 2026 | 6.330 |
| August 31, 2026 | 6.482 |
| August 28, 2026 | 6.120 |
| August 27, 2026 | 6.330 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.28 |
| Anika Therapeutics, Inc. | 1.652 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 0.9579 |
Price to Book Value Related Metrics
| PS Ratio | 1377.74 |
| Price | 1.855 |
| Earnings Yield | -105.0% |
| Market Cap | 4.612M |